A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus

Steven Fishbane, Aamir Z. Jamal, Catherine Munera, Warren Wen, Frédérique Menzaghi

New England Journal of Medicine · 2019 · 348 citations · 18 references

Abstract

Patients treated with difelikefalin had a significant reduction in itch intensity and improved itch-related quality of life as compared with those who received placebo. (Funded by Cara Therapeutics; KALM-1 ClinicalTrials.gov number, NCT03422653.).

References

18